Wedbush Starts Sutro Biopharma (STRO) at Outperform

October 22, 2018 6:18 AM EDT
Get Alerts STRO Hot Sheet
Price: $17.06 -3.23%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 12 | New: 23
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten initiates coverage on Sutro Biopharma (NASDAQ: STRO) with a Outperform rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Sutro Biopharma click here. For more ratings news on Sutro Biopharma click here.

Shares of Sutro Biopharma closed at $14.53 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage